Cargando…
Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases
BACKGROUND: There are few treatment options for patients with leptomeningeal metastases (LM). METHODS: We report a case series of patients with breast cancer and LM treated with intra‐CSF topotecan (TOPO). Outcome was assessed by clinical exam and MRI at baseline, at end of induction (4‐5 weeks), th...
Autores principales: | Jaeckle, Kurt A., Dixon, Jesse G., Anderson, Stephen Keith, Moreno‐Aspitia, Alvaro, Colon‐Otero, Gerardo, Hebenstreit, Kathy, Patel, Tejal A., Reddy, Samarth L., Perez, Edith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643683/ https://www.ncbi.nlm.nih.gov/pubmed/32885617 http://dx.doi.org/10.1002/cam4.3422 |
Ejemplares similares
-
Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma
por: Shackleford, Gregory M., et al.
Publicado: (2019) -
Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017) -
LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
por: Sinicrope, Kaylyn D, et al.
Publicado: (2019) -
Ovarian Adenocarcinoma With Leptomeningeal Metastases
por: Bayas, Angel, et al.
Publicado: (2022) -
Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
por: Apostolidis, Leonidas, et al.
Publicado: (2016)